#clinical trial — Sunday, June 07, 2026 (3 items)
| 0 | ℹ |
Cagrilintide-semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study.
(linkinghub.elsevier.com)
|
The Lancet 2026-06-07 | #clinical trial #diabetes #pharmacotherapy #glycemic control #insulin | |
| 0 | ℹ |
Survodutide Once Weekly for the Treatment of Adults with Obesity.
(nejm.org)
|
New England Journal of Medicine 2026-06-07 | #metabolism #clinical trial #pharmacotherapy #obesity | |
| 0 | ℹ |
Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial.
(nature.com)
|
Nature Medicine 2026-06-07 | #metabolism #clinical trial #obesity #fibrosis #steatosis |